Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine

Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine

Multiple sclerosis is the predominant autoimmune disorder affecting the central nervous system in adolescents and adults. Specific treatments are categorized as disease-modifying, whereas others are symptomatic treatments to alleviate painful symptoms. Currently, no singular conventional therapy is...

Full description

Bibliographic Details
Main Authors: Roua A. Nouh, Ahmed Kamal, Oluwaseyi Oyewole, Walaa A. Abbas, Bishoy Abib, Abdelrouf Omar, Somaia T. Mansour, Anwar Abdelnaser
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmaceutics
Subjects:
multiple sclerosis
autoimmune disease
cannabinoids
tetrahydrocannabinol
cannabis
treatment modalities
Online Access:https://www.mdpi.com/1999-4923/16/2/241

Internet

https://www.mdpi.com/1999-4923/16/2/241

Similar Items